Industry: Food & Beverages
Published Date: 2025-11-28
Pages: 209 Pages
Report ld: 5491992
Request Sample
Customized Report
Milk Infant Formula Market Size(US$)

CAGR 2025-2031
3.1%
Market Size,2031
USD 36,746
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Milk Infant Formula market is projected to grow from US$ 29752 million in 2024 to US$ 36746 million by 2031, at a CAGR of 3.1% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
In 2024, global Milk Infant Formula production reached approximately 2,118.51 K MT, with an average global market price of around US$ 14,200 per MT.
Milk Infant Formula is a specially designed powdered formula food for infants, intended to partially or completely replace breast milk when needed. It is typically based on cow’s milk or other dairy proteins, with carefully adjusted levels of fats, carbohydrates, vitamins, minerals and essential micronutrients to meet the nutritional requirements of early growth and development. Produced under strict food safety and regulatory standards, infant formula must be registered or approved by competent authorities, ensuring its composition is safe, digestible and nutritionally appropriate, and providing a consistent, controllable source of nutrition for babies who cannot be exclusively breastfed or require formula feeding.
From a supply chain perspective, the Milk Infant Formula industry can be broadly divided into three layers: upstream raw material and packaging suppliers, midstream formula development and manufacturing, and downstream distribution and end-market service. Upstream players provide fresh raw milk, skimmed milk powder, whey powder, lactose, vegetable oils, whey protein concentrates, vitamin–mineral premixes and other nutritional ingredients, along with cans, lids, composite films and labels for packaging; major global dairy groups typically combine owned and contracted farms with a global network of base powder and ingredient plants to secure high-quality milk and hedge regional and price volatility risks. Midstream is dominated by brand owners and their owned or contract factories, which handle formula design, raw-material qualification, spray-drying and blending, canning and nitrogen flushing, and finished-product testing under stringent regulatory oversight. In markets such as China, the EU and the U.S., authorities use recipe registration, tighter control of base powder and auxiliary materials, and on-site inspections to keep infant formula within a highly controlled quality and safety framework, raising both production and compliance barriers. Downstream, regional distributors, mother-and-baby specialty chains, supermarkets, e-commerce and cross-border platforms, as well as hospitals and pharmacies, form the main go-to-market channels, while in some countries government procurement and welfare programs are among the largest single buyers, reinforcing the dominance of a few large suppliers. Analyses of the 2022 U.S. infant formula shortage by regulators and national academies have highlighted how high concentration in a handful of plants and brands, dependence on specific ingredient and packaging vendors, and limited visibility along the chain amplified the impact of individual plant shutdowns, prompting the industry and policymakers to focus on capacity redundancy, diversified sourcing, better inventory strategies and more resilient, information-rich distribution networks.
Market Development Opportunities & Main Driving FactorsGlobally, the Milk Infant Formula market continues to show solid growth, supported by ongoing urbanization, a rising share of working mothers and growing awareness of the “first 1,000 days” as a critical nutrition window. Leading players report that infant nutrition businesses are delivering mid- to high single-digit growth, with premium offerings such as formulas enriched with Human Milk Oligosaccharides (HMOs), prebiotics, organic and A2 variants driving mix upgrade and margin expansion. In emerging markets, infant formula remains central to improving early-life nutrition, with multinational and local brands expanding reach through differentiated formulations, strong presence in mother-and-baby specialty stores and increasing e-commerce penetration. At the same time, a number of governments facing declining birth rates are introducing childcare subsidies and even free-milk initiatives, which help ease the cost of raising children and support medium- to long-term demand expectations for infant nutrition categories.
Market Challenges, Risks, & RestraintsThe industry also faces structural headwinds related to demographics, regulation and competition. In many developed economies and in key markets such as China, the number of newborns has been trending down, putting pressure on baseline demand for standard formulas, and several companies have publicly acknowledged volume declines in their China infant formula business. Meanwhile, regulators are tightening rules on formula registration, on-pack claims, cross-border trade and quality control, pushing formulations toward simplification while raising R&D and compliance costs. Any safety incident or recall can quickly escalate into a serious brand and channel crisis. Competitive intensity remains high, with global giants, strong domestic champions and regional brands all vying for share in organic, premium and specialized segments. Price warfare and aggressive promotions still occur, and the high transparency of online pricing further squeezes margins, especially for mid- and low-tier brands.
Downstream Demand TrendsOn the demand side, the market is characterized by relatively stable or slowing volumes but clear value-mix upgrading. Even as birth numbers soften, parents are willing to spend more per child on safety and science-backed nutrition, accelerating the shift toward premium, organic, A2, HMO/prebiotic-enriched and specialized medical formulas, which are capturing a growing share of category value. Channel dynamics are also evolving: offline mother-and-baby specialty chains remain critical for brand building and professional advisory services, while e-commerce, direct-to-consumer stores and cross-border platforms continue to gain share, with live-streaming and large online campaigns becoming key tools for consumer education and acquisition. Regionally, China is going through a period of destocking and structural adjustment toward more premium and differentiated offerings, while fast-growing Asian, Middle Eastern, African and Latin American markets are contributing incremental volume and value. Looking ahead, companies that can combine rigorous safety and traceability with credible nutrition science, sustainability and truly omnichannel engagement with new-generation parents will be best positioned to build durable competitive advantages in the Milk Infant Formula market.
Report Includes:
This definitive report equips business leaders, decision-makers and stakeholders with a 360° view of the global Milk Infant Formula market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Sales Channel, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region's dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Defines the Milk Infant Formula study scope, segments the market by Type and by Sales Channel, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Sales Channel, identifies emerging use cases, and profiles leading customers by region and by Sales Channel.
Chapter 6: North America—breaks down sales and revenue by Type, by Sales Channel and country, profiles key manufacturers and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Sales Channel and manufacturers, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Sales Channel, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures sales and revenue by Type, by Sales Channel, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Sales Channel, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; top manufactures 2024 sales breakdowns by product type, by Sales Channel, by sales region SWOT analysis, and recent strategic developments.
Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 15: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Introduction to Milk Infant Formula: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Milk Infant Formula Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Cow Milk Powder
1.2.3 Goat Milk Powder
1.2.4 Other
1.3 Market Segmentation by Sales Channel
1.3.1 Global Milk Infant Formula Market Size by Sales Channel, 2020 VS 2024 VS 2031
1.3.2 Maternal Stores
1.3.3 Supermarkets/Hypermarkets
1.3.4 Online Retail
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Milk Infant Formula Revenue Estimates and Forecasts 2020-2031
2.2 Global Milk Infant Formula Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Milk Infant Formula Sales Estimates and Forecasts 2020-2031
2.4 Global Milk Infant Formula Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global Milk Infant Formula Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global Milk Infant Formula Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 Cow Milk Powder Market Size by Manufacturers
3.5.2 Goat Milk Powder Market Size by Manufacturers
3.5.3 Other Market Size by Manufacturers
3.6 Global Milk Infant Formula Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Milk Infant Formula Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global Milk Infant Formula Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Milk Infant Formula Sales by Sales Channel
5.1.1 Global Historical and Forecasted Sales by Sales Channel (2020-2031)
5.1.2 Global Sales Market Share by Sales Channel (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Milk Infant Formula Revenue by Sales Channel
5.2.1 Global Historical and Forecasted Revenue by Sales Channel (2020-2031)
5.2.2 Revenue Market Share by Sales Channel (2020-2031)
5.3 Global Pricing Dynamics by Sales Channel (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Sales Channel
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America Milk Infant Formula Sales and Revenue by Type (2020-2031)
6.4 North America Milk Infant Formula Sales and Revenue by Sales Channel (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Milk Infant Formula Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe Milk Infant Formula Sales and Revenue by Type (2020-2031)
7.4 Europe Milk Infant Formula Sales and Revenue by Sales Channel (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Milk Infant Formula Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 UK
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific Milk Infant Formula Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific Milk Infant Formula Sales and Revenue by Sales Channel (2020-2031)
8.5 Asia-Pacific Milk Infant Formula Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America Milk Infant Formula Sales and Revenue by Type (2020-2031)
9.4 Central and South America Milk Infant Formula Sales and Revenue by Sales Channel (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Milk Infant Formula Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa Milk Infant Formula Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa Milk Infant Formula Sales and Revenue by Sales Channel (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Milk Infant Formula Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Danone
11.1.1 Danone Corporation Information
11.1.2 Danone Business Overview
11.1.3 Danone Milk Infant Formula Product Models, Descriptions and Specifications
11.1.4 Danone Milk Infant Formula Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 Danone Milk Infant Formula Sales by Product in 2024
11.1.6 Danone Milk Infant Formula Sales by Sales Channel in 2024
11.1.7 Danone Milk Infant Formula Sales by Geographic Area in 2024
11.1.8 Danone Milk Infant Formula SWOT Analysis
11.1.9 Danone Recent Developments
11.2 Nestle
11.2.1 Nestle Corporation Information
11.2.2 Nestle Business Overview
11.2.3 Nestle Milk Infant Formula Product Models, Descriptions and Specifications
11.2.4 Nestle Milk Infant Formula Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 Nestle Milk Infant Formula Sales by Product in 2024
11.2.6 Nestle Milk Infant Formula Sales by Sales Channel in 2024
11.2.7 Nestle Milk Infant Formula Sales by Geographic Area in 2024
11.2.8 Nestle Milk Infant Formula SWOT Analysis
11.2.9 Nestle Recent Developments
11.3 Abbott
11.3.1 Abbott Corporation Information
11.3.2 Abbott Business Overview
11.3.3 Abbott Milk Infant Formula Product Models, Descriptions and Specifications
11.3.4 Abbott Milk Infant Formula Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 Abbott Milk Infant Formula Sales by Product in 2024
11.3.6 Abbott Milk Infant Formula Sales by Sales Channel in 2024
11.3.7 Abbott Milk Infant Formula Sales by Geographic Area in 2024
11.3.8 Abbott Milk Infant Formula SWOT Analysis
11.3.9 Abbott Recent Developments
11.4 Reckiit
11.4.1 Reckiit Corporation Information
11.4.2 Reckiit Business Overview
11.4.3 Reckiit Milk Infant Formula Product Models, Descriptions and Specifications
11.4.4 Reckiit Milk Infant Formula Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 Reckiit Milk Infant Formula Sales by Product in 2024
11.4.6 Reckiit Milk Infant Formula Sales by Sales Channel in 2024
11.4.7 Reckiit Milk Infant Formula Sales by Geographic Area in 2024
11.4.8 Reckiit Milk Infant Formula SWOT Analysis
11.4.9 Reckiit Recent Developments
11.5 Biostime
11.5.1 Biostime Corporation Information
11.5.2 Biostime Business Overview
11.5.3 Biostime Milk Infant Formula Product Models, Descriptions and Specifications
11.5.4 Biostime Milk Infant Formula Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 Biostime Milk Infant Formula Sales by Product in 2024
11.5.6 Biostime Milk Infant Formula Sales by Sales Channel in 2024
11.5.7 Biostime Milk Infant Formula Sales by Geographic Area in 2024
11.5.8 Biostime Milk Infant Formula SWOT Analysis
11.5.9 Biostime Recent Developments
11.6 Bellamy
11.6.1 Bellamy Corporation Information
11.6.2 Bellamy Business Overview
11.6.3 Bellamy Milk Infant Formula Product Models, Descriptions and Specifications
11.6.4 Bellamy Milk Infant Formula Sales, Price, Revenue and Gross Margin (2020-2025)
11.6.5 Bellamy Recent Developments
11.7 Topfer
11.7.1 Topfer Corporation Information
11.7.2 Topfer Business Overview
11.7.3 Topfer Milk Infant Formula Product Models, Descriptions and Specifications
11.7.4 Topfer Milk Infant Formula Sales, Price, Revenue and Gross Margin (2020-2025)
11.7.5 Topfer Recent Developments
11.8 HiPP
11.8.1 HiPP Corporation Information
11.8.2 HiPP Business Overview
11.8.3 HiPP Milk Infant Formula Product Models, Descriptions and Specifications
11.8.4 HiPP Milk Infant Formula Sales, Price, Revenue and Gross Margin (2020-2025)
11.8.5 HiPP Recent Developments
11.9 Perrigo
11.9.1 Perrigo Corporation Information
11.9.2 Perrigo Business Overview
11.9.3 Perrigo Milk Infant Formula Product Models, Descriptions and Specifications
11.9.4 Perrigo Milk Infant Formula Sales, Price, Revenue and Gross Margin (2020-2025)
11.9.5 Perrigo Recent Developments
11.10 Humana
11.10.1 Humana Corporation Information
11.10.2 Humana Business Overview
11.10.3 Humana Milk Infant Formula Product Models, Descriptions and Specifications
11.10.4 Humana Milk Infant Formula Sales, Price, Revenue and Gross Margin (2020-2025)
11.10.5 Humana Recent Developments
11.11 Nutribio
11.11.1 Nutribio Corporation Information
11.11.2 Nutribio Business Overview
11.11.3 Nutribio Milk Infant Formula Product Models, Descriptions and Specifications
11.11.4 Nutribio Milk Infant Formula Sales, Price, Revenue and Gross Margin (2020-2025)
11.11.5 Nutribio Recent Developments
11.12 Meiji
11.12.1 Meiji Corporation Information
11.12.2 Meiji Business Overview
11.12.3 Meiji Milk Infant Formula Product Models, Descriptions and Specifications
11.12.4 Meiji Milk Infant Formula Sales, Price, Revenue and Gross Margin (2020-2025)
11.12.5 Meiji Recent Developments
11.13 a2 Milk
11.13.1 a2 Milk Corporation Information
11.13.2 a2 Milk Business Overview
11.13.3 a2 Milk Milk Infant Formula Product Models, Descriptions and Specifications
11.13.4 a2 Milk Milk Infant Formula Sales, Price, Revenue and Gross Margin (2020-2025)
11.13.5 a2 Milk Recent Developments
11.14 Ausnutria
11.14.1 Ausnutria Corporation Information
11.14.2 Ausnutria Business Overview
11.14.3 Ausnutria Milk Infant Formula Product Models, Descriptions and Specifications
11.14.4 Ausnutria Milk Infant Formula Sales, Price, Revenue and Gross Margin (2020-2025)
11.14.5 Ausnutria Recent Developments
11.15 Feihe
11.15.1 Feihe Corporation Information
11.15.2 Feihe Business Overview
11.15.3 Feihe Milk Infant Formula Product Models, Descriptions and Specifications
11.15.4 Feihe Milk Infant Formula Sales, Price, Revenue and Gross Margin (2020-2025)
11.15.5 Feihe Recent Developments
11.16 Yili
11.16.1 Yili Corporation Information
11.16.2 Yili Business Overview
11.16.3 Yili Milk Infant Formula Product Models, Descriptions and Specifications
11.16.4 Yili Milk Infant Formula Sales, Price, Revenue and Gross Margin (2020-2025)
11.16.5 Yili Recent Developments
11.17 Yashili
11.17.1 Yashili Corporation Information
11.17.2 Yashili Business Overview
11.17.3 Yashili Milk Infant Formula Product Models, Descriptions and Specifications
11.17.4 Yashili Milk Infant Formula Sales, Price, Revenue and Gross Margin (2020-2025)
11.17.5 Yashili Recent Developments
11.18 Bright Dairy & Food
11.18.1 Bright Dairy & Food Corporation Information
11.18.2 Bright Dairy & Food Business Overview
11.18.3 Bright Dairy & Food Milk Infant Formula Product Models, Descriptions and Specifications
11.18.4 Bright Dairy & Food Milk Infant Formula Sales, Price, Revenue and Gross Margin (2020-2025)
11.18.5 Bright Dairy & Food Recent Developments
11.19 Junlebao
11.19.1 Junlebao Corporation Information
11.19.2 Junlebao Business Overview
11.19.3 Junlebao Milk Infant Formula Product Models, Descriptions and Specifications
11.19.4 Junlebao Milk Infant Formula Sales, Price, Revenue and Gross Margin (2020-2025)
11.19.5 Junlebao Recent Developments
11.20 Beingmate
11.20.1 Beingmate Corporation Information
11.20.2 Beingmate Business Overview
11.20.3 Beingmate Milk Infant Formula Product Models, Descriptions and Specifications
11.20.4 Beingmate Milk Infant Formula Sales, Price, Revenue and Gross Margin (2020-2025)
11.20.5 Beingmate Recent Developments
11.21 Wonder Sun
11.21.1 Wonder Sun Corporation Information
11.21.2 Wonder Sun Business Overview
11.21.3 Wonder Sun Milk Infant Formula Product Models, Descriptions and Specifications
11.21.4 Wonder Sun Milk Infant Formula Sales, Price, Revenue and Gross Margin (2020-2025)
11.21.5 Wonder Sun Recent Developments
11.22 Wissun
11.22.1 Wissun Corporation Information
11.22.2 Wissun Business Overview
11.22.3 Wissun Milk Infant Formula Product Models, Descriptions and Specifications
11.22.4 Wissun Milk Infant Formula Sales, Price, Revenue and Gross Margin (2020-2025)
11.22.5 Wissun Recent Developments
11.23 YeePer
11.23.1 YeePer Corporation Information
11.23.2 YeePer Business Overview
11.23.3 YeePer Milk Infant Formula Product Models, Descriptions and Specifications
11.23.4 YeePer Milk Infant Formula Sales, Price, Revenue and Gross Margin (2020-2025)
11.23.5 YeePer Recent Developments
11.24 Synutra
11.24.1 Synutra Corporation Information
11.24.2 Synutra Business Overview
11.24.3 Synutra Milk Infant Formula Product Models, Descriptions and Specifications
11.24.4 Synutra Milk Infant Formula Sales, Price, Revenue and Gross Margin (2020-2025)
11.24.5 Synutra Recent Developments
11.25 Mengniu Dairy
11.25.1 Mengniu Dairy Corporation Information
11.25.2 Mengniu Dairy Business Overview
11.25.3 Mengniu Dairy Milk Infant Formula Product Models, Descriptions and Specifications
11.25.4 Mengniu Dairy Milk Infant Formula Sales, Price, Revenue and Gross Margin (2020-2025)
11.25.5 Mengniu Dairy Recent Developments
11.26 Holle
11.26.1 Holle Corporation Information
11.26.2 Holle Business Overview
11.26.3 Holle Milk Infant Formula Product Models, Descriptions and Specifications
11.26.4 Holle Milk Infant Formula Sales, Price, Revenue and Gross Margin (2020-2025)
11.26.5 Holle Recent Developments
11.27 Nestle
11.27.1 Nestle Corporation Information
11.27.2 Nestle Business Overview
11.27.3 Nestle Milk Infant Formula Product Models, Descriptions and Specifications
11.27.4 Nestle Milk Infant Formula Sales, Price, Revenue and Gross Margin (2020-2025)
11.27.5 Nestle Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 Milk Infant Formula Industry Chain
12.2 Milk Infant Formula Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Milk Infant Formula Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Milk Infant Formula Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Milk Infant Formula Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Milk Infant Formula Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Milk Infant Formula market size was US$ 30560 million in 2025 and is forecast to reach a readjusted size of US$ 37780 million by 2032 with a CAGR of 3.1% during the forecast period 2026-2032.
Published Date: 2026-03-09
Pages: 121
USD 4250.00
(Single User License)
The global Milk Infant Formula market is projected to grow from US$ 30560 million in 2025 to US$ 37780 million by 2032, at a CAGR of 3.1% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-09
Pages: 214
USD 4900.00
(Single User License)
The global market for Milk Infant Formula was estimated to be worth US$ 30560 million in 2025 and is projected to reach US$ 37780 million, growing at a CAGR of 3.1% from 2026 to 2032.
Published Date: 2026-03-05
Pages: 187
USD 3950.00
(Single User License)
The global Milk Infant Formula market was valued at US$ 30560 million in 2025 and is anticipated to reach US$ 37780 million by 2032, at a CAGR of 3.1% from 2026 to 2032.
Published Date: 2026-03-05
Pages: 151
USD 2900.00
(Single User License)
The global market for Milk Infant Formula was estimated to be worth US$ 29752 million in 2024 and is forecast to a readjusted size of US$ 36746 million by 2031 with a CAGR of 3.1% during the forecast period 2025-2031.
Published Date: 2025-11-28
Pages: 183
USD 3950.00
(Single User License)
The global Milk Infant Formula market size was US$ 29752 million in 2024 and is forecast to a readjusted size of US$ 36746 million by 2031 with a CAGR of 3.1% during the forecast period 2025-2031.
Published Date: 2025-11-28
Pages: 128
USD 4250.00
(Single User License)
The global market for Milk Infant Formula was valued at US$ 29752 million in the year 2024 and is projected to reach a revised size of US$ 36746 million by 2031, growing at a CAGR of 3.1% during the forecast period.
Published Date: 2025-11-28
Pages: 118
USD 2900.00
(Single User License)
The global market for Milk Infant Formula was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-27
Pages: 168
USD 3950.00
(Single User License)
Milk Infant Formula is usually made from cows' milk that has been treated to make it more suitable for babies.
Published Date: 2024-04-22
Pages: 129
USD 4900.00
(Single User License)
Milk Infant Formula is usually made from cows' milk that has been treated to make it more suitable for babies.
Published Date: 2024-01-24
Pages: 167
USD 3950.00
(Single User License)
The global Milk Infant Formula market size was US$ 30560 million in 2025 and is forecast to reach a readjusted size of US$ 37780 million by 2032 with a CAGR of 3.1% during the forecast period 2026-2032.
Published: 2026-03-09
Pages: 121
The global Milk Infant Formula market is projected to grow from US$ 30560 million in 2025 to US$ 37780 million by 2032, at a CAGR of 3.1% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-09
Pages: 214
The global market for Milk Infant Formula was estimated to be worth US$ 30560 million in 2025 and is projected to reach US$ 37780 million, growing at a CAGR of 3.1% from 2026 to 2032.
Published: 2026-03-05
Pages: 187
The global Milk Infant Formula market was valued at US$ 30560 million in 2025 and is anticipated to reach US$ 37780 million by 2032, at a CAGR of 3.1% from 2026 to 2032.
Published: 2026-03-05
Pages: 151
The global market for Milk Infant Formula was estimated to be worth US$ 29752 million in 2024 and is forecast to a readjusted size of US$ 36746 million by 2031 with a CAGR of 3.1% during the forecast period 2025-2031.
Published: 2025-11-28
Pages: 183
The global Milk Infant Formula market size was US$ 29752 million in 2024 and is forecast to a readjusted size of US$ 36746 million by 2031 with a CAGR of 3.1% during the forecast period 2025-2031.
Published: 2025-11-28
Pages: 128
The global market for Milk Infant Formula was valued at US$ 29752 million in the year 2024 and is projected to reach a revised size of US$ 36746 million by 2031, growing at a CAGR of 3.1% during the forecast period.
Published: 2025-11-28
Pages: 118
The global market for Milk Infant Formula was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-27
Pages: 168
Milk Infant Formula is usually made from cows' milk that has been treated to make it more suitable for babies.
Published: 2024-04-22
Pages: 129
Milk Infant Formula is usually made from cows' milk that has been treated to make it more suitable for babies.
Published: 2024-01-24
Pages: 167
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now